Please upgrade your browser.
Both the fixed and randomeffects models were used to obtain the summary risk estimates associated with the highest versus the lowest consumption categories depending on the heterogeneity of effects among studies.
My older brother started the charity toward the end of our dads life. Our dad was diagnosed with kidney cancer in the 1990s, and it returned in the early 2000s. Scott has been so heavily involved its truly his calling in life. Ive always been on the periphery. You cant be close to someone who is doing something incredible and not get involved or help out in some way."
Also in the late-stage pipeline are renal cell carcinoma drug axitinib and tofacitinib, for rheumatoid arthritis and other autoimmune disorders.
OHSU Knight Cancer Institute study uncovers role of gene in renal cancers that dont respond to current therapies but could be helped by existing FDA-approved drug
Volume 9, Number 1 - 2011 - Official Journal of the Kidney Cancer Association
Why are clinical trials still important with all these new drugs for treating advanced kidney cancer?
Dr. Walter Stadler talks about a clinical trial that is in danger of being discontinued, due to a lack of participation. This month's video also features a spirited pro/con debate from the European International Kidney Cancer Symposium. Watch the video to learn what the controversy is about.
Cancer Research UK scientists have found that blocking the pathway used by some kidney cancer cells to generate energy can kill the cancer cells, sparing the healthy ones.
A Boehringer Ingelheim GmbH plant that has caused shortages in drug supplies will exit the pharmaceutical contract-manufacturing business as it faces a Canadian ban on the importation of some of its drugs.
Research carried out by scientists at the San Diego School of Medicine emphasizes the importance of kidney-sparing surgery to reduce the risk of later-life osteoporosis.
|Powered by NeonCRM|